Since its launch in 2013, the AllTrials campaign has achieved a lot in Europe and has been a strong and powerful voice for advocating the registration and reporting of all clinical trials. This initiative has now moved across the Atlantic and yesterday, Sense About Science USA launched the long awaited AllTrials US campaign.
In recent decades, the reproducibility of a shocking number of scientific studies has been called into question. What we’re going to do about the reproducibility ‘crisis’ is a question for everyone involved in research. Today, in an effort to address this BioMed Central is launching the pilot of a new Minimum Standards of Reporting Checklist.
Today the new open access policy of Canada’s International Development Research Centre comes into force. In this guest post, Naser Faruqui, Director of IDRC’s Technology and Innovation Program, explains the policy and why they’ve put it in place.
Poor reporting plagues scientific literature, severely limiting the usability and usefulness of published research results which impacts patient care. Following the recent publication of guidelines to help resolve this issue, Dr Hayley Tyrer reveals her thoughts on this textbook, and how it could be used.
The recent release of the Thomson Reuters Impact Factors has once again sparked an ongoing debate around the value and insight that such metrics can offer, and their role in the evaluation of research. Here, Catherine Chimes discusses more about what metrics tell us.